# Cilostazol for Prevention of Recurrent Stroke Trial

Study · id `cardio:ct-nct07174414` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07174414](<https://clinicaltrials.gov/study/NCT07174414>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07174414

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT07174414. Randomized; quadruple masking; primary purpose prevention. Start 2026-10-15 (actual); primary completion 2031-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT07174414, source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)
- Started: 2026-10-15 (actual) (ClinicalTrials.gov record NCT07174414, source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2031-07 (anticipated) (ClinicalTrials.gov record NCT07174414, source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)
- Completion: 2031-07 (anticipated) (ClinicalTrials.gov record NCT07174414, source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07174414, source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07174414-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Cilostazol for Prevention of Recurrent Stroke Trial
- Acronym: Clarity
- Condition: Stroke Recurrence
- Condition: Myocardial Infarction
- Condition: Vascular Death
- Condition: Ischemic Stroke
- Condition: TIA (Transient Ischemic Attack)
- Condition: Stroke (CVA) or Transient Ischemic Attack
- Condition: Recurrent Stroke
- Intervention (Drug): Cilostazol 100 mg Tablets
- Intervention (Drug): Placebo
- Lead sponsor: Stanford University
- Lead sponsor class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: Yale University
- Collaborator class: OTHER
- Collaborator: University of Cincinnati
- Collaborator class: OTHER
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Stanford University (`cardio:org-stanford-university`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)
- Registry lists this organization as a collaborator: Yale University (`cardio:org-yale-university`)
- Registry lists this organization as a collaborator: University of Cincinnati (`cardio:org-university-of-cincinnati`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)

## Provenance

Content hash: 94f0d10e3d91e35b4273f134cf2ce03e8adcda58218cfd3fd2017b924d042641
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
